by GlobeNewsWire | Nov 18, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Nov. 18, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by GlobeNewsWire | Nov 5, 2015 | Globe Newswire
NEW YORK, Nov. 05, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases,...
by editor | Nov 3, 2015 | Buzz
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]Yes, we’ve been all over Anavex Life Sciences Corp (NASDAQ: AVXL, AVXLD recently) for MONTHS. Since we started, things have gone from very good to GREAT. Things have gone from Over the Counter to...
by GlobeNewsWire | Oct 29, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]ADVISORY, Oct. 29, 2015 (GLOBE NEWSWIRE) –What: Anavex Life Sciences Corp. (Nasdaq:AVXL), a clinical-stage biopharmaceutical company that is developing drug candidates for Alzheimer’s disease,...
by editor | Oct 28, 2015 | Buzz
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]I will admit this one post is pure click bait. I keep getting asked this question:”Are you being paid to promote Anavex Life Sciences Corp. (Nasdaq!: AVXL / AVXLD)?”Here’s an answer I...
